Tags » MHRA

Critiquing Criticism: From the Ancient to the Digital

‘Critiquing Criticism: From the Ancient to the Digital’

We are very pleased to announce the publication of MHRA Working Papers in the Humanities volume 10 (2015) ‘Critiquing Criticism: From the Ancient to the Digital’. 133 more words

Publications Of Interest

CFP: Have you Heard…? Navigating the Interstices Between Public and Private Knowledge

Have you Heard…?

Navigating the Interstices Between Public and Private Knowledge

The annual MHRA Conference

Friday, 14 October 2016

at the Institute of Modern Languages Research, 392 more words

Events Of Interest

Guidance for filling in the MHRA Consultation

The MHRA, who will be the regulators in the UK for the TPD are asking for responses to a consultation on their proposals – full document  429 more words

Advocacy

Patient safety alert – Risk of death and serious harm by falling from hoists

Source: NHS England

Follow this link for item

Date of publication: October 2015

Publication type: Safety alert

In a nutshell:  A joint patient safety alert has been issued by NHS England and the Medicines & Healthcare products Regulatory Agency (MHRA) to highlight the risk of falls from hoists.  75 more words

Volume 6 Issue 11

MHRA PG Editor and PG Representative

The MHRA (Modern Humanities Research Association) is looking for a second postgraduate editor for its online journal, MHRA Working Papers in the HumanitiesWorking Papers… 199 more words

Events Of Interest

What changed?

Pro-pharma bias in the NICE menopause guidelines

Last week’s headlines about NICE’s (National Institute of Clinical Excellence) new menopause guidelines (click here) will have pleased the hormone therapy (HT*) manufacturers. 773 more words

Health General

UK’s MHRA Calls Out GSK China Plant Over GMP Non-Compliance

http://www.raps.org/Regulatory-Focus/News/2015/10/23/23467/UK%E2%80%99s-MHRA-Calls-Out-GSK-China-Plant-Over-GMP-Non-Compliance/

Home / Regulatory Focus / News

UK’s MHRA Calls Out GSK China Plant Over GMP Non-Compliance

Posted 23 October 2015 By Zachary Brennan

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Friday released an inspection report that found a GlaxoSmithKline (GSK) manufacturing facility in Tianjin, China was non-compliant with Good Manufacturing Practices (GMPs). 334 more words

Seroxat